Published in

Elsevier, EBioMedicine, (62), p. 103098, 2020

DOI: 10.1016/j.ebiom.2020.103098

Links

Tools

Export citation

Search in Google Scholar

IgM-Rheumatoid factor confers primary resistance to anti-PD-1 immunotherapies in NSCLC patients by reducing CD137+T-cells

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO